STING1 and neoplasm: Other combinational strategies, such as anti-PD1 and COX2 inhibition, have been reported to enhance the anti-tumor effect of STING agonist in a mouse model of Lewis lung carcinoma (61), indicating that more strategies of adaptive therapy combined with STING agonist need to be tested.